CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.
Age ≥ 18 years;
Diagnosis of type 2 diabetes mellitus (T2DM);
Stable clinical conditions
Outpatient settings
Patients with type 1 diabetes mellitus;
Active participation in interventional studies;
Any condition that may put the patient at risk by participating in the study.
Consecutive diabetic patients attending the outpatient clinics, in primary and secondary prevention of cardiovascular disease.
Cohort
Other
data collection
Other interventionData collection on diabetes therapy and follow-up
Diabetes treatment adherence according to the most recent European Guidelines
Outpatients clinic treatment adherence will be measured as the percentage of patients receiving guideline-directed medical therapy prescriptions.
Click on the lead sponsor to view all of their trials.
